Last reviewed · How we verify
NCT07535476: M-DICER
Predictors of Clinical Response After Interlaminar Cervical Epidural Steroid Injection for Cervical Radiculopathy
trial in Radiculopathy, Cervical Region in 107 participants. Completed in 10 April 2026.
1 April 2026
Quick facts
| Lead sponsor | Mersin University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 107 |
| Start date | 1 January 2018 |
| Primary completion | 1 April 2026 |
| Estimated completion | 10 April 2026 |
| Sites | 1 location across Turkey (Türkiye) |
Conditions studied
- Radiculopathy, Cervical Region — all drugs for Radiculopathy, Cervical Region →
- Neck Pain — all drugs for Neck Pain →
- Disc Disease — all drugs for Disc Disease →
- Radicular Pain — all drugs for Radicular Pain →
Sponsor
Mersin University
Who can join
18 and older, any sex, with Radiculopathy, Cervical Region or Neck Pain. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Cervical epidural steroid injection is a commonly used treatment option for patients with cervical radicular pain who do not improve adequately with conservative treatment. Cervical radicular pain typically radiates from the neck to the shoulder, arm, or hand and may be accompanied by numbness, weakness or changes in reflexes. The most common causes are cervical disc herniation and cervical spondylosis. By reducing inflammation around the affected nerve root, epidural steroid injection may help relieve pain and improve function. Among available techniques, the interlaminar approach is frequently preferred in the cervical region because of its technical feasibility and safety profile. Although interlaminar cervical epidural steroid injection is widely used, treatment response varies among patients, and not all individuals experience the same degree of benefit. Identifying the factors associated with better or poorer clinical response may help improve patient selection and reduce unnecessary procedures. This retrospective cohort study aims to evaluate clinical outcomes after interlaminar cervical epidural steroid injection in patients with cervical radiculopathy and to investigate demographic, clinical, and procedure-related variables which may predict treatment response. By analyzing pain scores before and after the procedure, this study seeks to better define the predictors of clinical outcome following this intervention.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07535476
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Radiculopathy, Cervical Region
Currently open trials in the same condition.
- NCT04623593 — Cervical Arthroplasty Cost Effectiveness Study (CACES) · NA · recruiting
Other Mersin University trials
Trials by the same sponsor.
- NCT06942702 — Efficacy of Genicular Block on Total Knee Arthroplasty Surgery · NA · not yet recruiting
- NCT07516249 — Effects of Cartoons & Interactive Storytelling on Fear and Comfort in 6-9 Year Olds During Nebulizer Treatment · NA · not yet recruiting
- NCT07507656 — The Effect of a Stress Ball Applied Before Retrograde Intrarenal Surgery on Anxiety, Surgical Fear, and Hemodynamic Para · NA · not yet recruiting
- NCT07507617 — The Effect of Using a Stress Ball During Transrectal Ultrasound-Guided Prostate Biopsy on Anxiety, Pain, and Hemodynamic · NA · not yet recruiting
- NCT07495501 — Patient Satisfaction During Lomber Transforaminal Epidural Steroid Injection: The Role of Sedation, Anxiety, and Pain · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07535476 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Mersin University
- Last refreshed: 17 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07535476.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing